Matthew H. Wilson MD PhD is a Professor of Medicine in the Division of Nephrology and Hypertension at Vanderbilt where he holds the Ruth King Scoville endowed chair in Medicine. He is also a Professor of Cell and Developmental Biology and Pharmacology. He is an alumnus of the Vanderbilt Medical Scientist Training Program, where he was awarded the Albert Weinstein Prize in Medicine upon graduation, and he is an alumnus of the Vanderbilt Physician Scientist Training Program where he trained in Internal Medicine and Nephrology. Dr. Wilson began his career at Baylor College of Medicine where he was a member of the Center for Cell and Gene Therapy before returning to Vanderbilt in 2013. He has served as a member of the board of directors for the American Society of Gene + Cell Therapy. Dr. Wilson’s research focuses on genome engineering, gene transfer including the piggyBac transposon system for a variety of applications, and engineering cell and gene therapies for kidney disease. His research is funded by the NIH, VA including a VA Senior Clinician Scientist Investigator Award, and other sponsored research agreements. Dr. Wilson serves as an attending on the inpatient medicine and nephrology services and outpatient nephrology clinic at the Nashville VA.